Chagas cardiomiopathy: The potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage

PLoS Neglected Tropical Diseases

Volumn 4, Issue 9, 2010, Pages

  Garcia Alvarez, Ana ^a,b   Sitges, Marta ^a,c   Pinazo, María Jesús ^d   Regueiro Cueva, Ander ^a   Posada, Elizabeth ^d   Poyatos, Silvia ^a   Ortiz Pérez, José Tomás ^a   Heras, Magda ^a,c   Azqueta, Manel ^a,c   Gascon, Joaquim ^d   Sanz, Ginés ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; EARLY DIAGNOSIS; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE RELAXATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIDE ANALYSIS; PROSPECTIVE STUDY; SEROLOGY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD; DIASTOLE; ECHOCARDIOGRAPHY; EVALUATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SOUTH AND CENTRAL AMERICA;

ADULT; BIOLOGICAL MARKERS; CHAGAS CARDIOMYOPATHY; DIASTOLE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; SENSITIVITY AND SPECIFICITY;

EID: 78049531133     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000826     Document Type: Article

References (35)

1. Jannin J, Villa L (2007) An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz 102 Suppl 1: 95-97.
2. Schmunis GA (2007) Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102 Suppl 1: 75-85.
3. Schmunis GA, Yadon ZE (2009) Chagas disease: A Latin American health problem becoming a world health problem. Acta Trop. In press.
4. Munoz J, Gomez i Prat J, Gallego M, Gimeno F, Trevino B, et al. (2009) Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop 111: 51-55.
5. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
6. Pelliccia A, Culasso F, Di Paolo FM, Accettura D, Cantore R, et al. (2007) Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. Eur Heart J 28: 2006-2010.
7. Miller WL, Hodge DO, Hammill SC (2008) Association of uncomplicated electrocardiographic conduction blocks with subsequent cardiac morbidity in a community-based population (Olmsted County, Minnesota). Am J Cardiol 101: 102-106.
8. Marin-Neto JA, Rassi A, Jr., Avezum A, Jr., Mattos AC, Rassi A (2009) The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz 104 Suppl 1: 319-324.
9. Rassi A, Jr., Rassi A, Little WC, Xavier SS, Rassi SG, et al. (2006) Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 355: 799-808.
10. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al. (2009) 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: e391-479.
11. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, et al. (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22: 107-133.
12. Bijnens BH, Cikes M, Claus P, Sutherland GR (2009) Velocity and deformation imaging for the assessment of myocardial dysfunction. Eur J Echocardiogr 10: 216-226.
13. Barros MV, Ribeiro AL, Machado FS, Rocha MO (2003) Doppler tissue imaging to assess systolic function in Chagas' disease. Arq Bras Cardiol 80: 36-40, 31-35.
14. Barbosa MM, Nunes Mdo C, Ribeiro AL, Barral MM, Rocha MO (2007) Nterminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle. Eur J Echocardiogr 8: 204-212.
15. Barros MV, Machado FS, Ribeiro AL, Rocha MO (2004) Diastolic function in Chagas' disease: an echo and tissue Doppler imaging study. Eur J Echocardiogr 5: 182-188.
16. Barros MV, Rocha MO, Ribeiro AL, Machado FS (2001) Doppler tissue imaging to evaluate early myocardium damage in patients with undetermined form of Chagas' disease and normal echocardiogram. Echocardiography 18: 131-136.
17. Cianciulli TF, Lax JA, Saccheri MC, Papantoniou A, Morita LA, et al. (2006) Early detection of left ventricular diastolic dysfunction in Chagas' disease. Cardiovasc Ultrasound 4: 18.
18. Pazin-Filho A, Romano MM, Gomes Furtado R, de Almeida Filho OC, Schmidt A, et al. (2007) Left ventricular global performance and diastolic function in indeterminate and cardiac forms of Chagas' disease. J Am Soc Echocardiogr 20: 1338-1343.
19. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, et al. (1996) Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 9: 736-760.
20. Silva CE, Ferreira LD, Peixoto LB, Monaco CG, Gil MA, et al. (2005) [Evaluation of segmentary contractility in Chagas' disease by using the integral of the myocardial velocity gradient (myocardial strain) obtained through tissue Doppler echocardiography]. Arquivos Brasileiros de Cardiologia 84: 285-291.
21. Acquatella H (2007) Echocardiography in Chagas heart disease. Circulation 115: 1124-1131.
22. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, et al. (2005) Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 46: 1553-1558.
23. Scaglione J, Puyo AM, Dupuy HA, Postan M, Fernandez BE (2001) Behavior of atrial natriuretic factor in an experimental model of Trypanosoma cruzi infection in rats. J Parasitol 87: 923-926.
24. Piazza LA, de Bold AJ, Santamarina N, Hliba E, Rubiolo ER (1994) Atrial natriuretic factor in experimental acute Chagas' disease. Parasitol Res 80: 78-80.
25. Ribeiro AL, dos Reis AM, Barros MV, de Sousa MR, Rocha AL, et al. (2002) Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease. Lancet 360: 461-462.
26. Ribeiro AL, Teixeira MM, Reis AM, Talvani A, Perez AA, et al. (2006) Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach. Int J Cardiol 109: 34-40.
27. Talvani A, Rocha MO, Cogan J, Maewal P, de Lemos J, et al. (2004) Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy. Mem Inst Oswaldo Cruz 99: 645-649.
28. Moreira Mda C, Wang Y, Heringer-Walther S, Wessel N, Walther T (2009) Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides. Congest Heart Fail 15: 75-81.
29. Oliveira BM, Botoni FA, Ribeiro AL, Pinto AS, Reis AM, et al. (2009) Correlation between BNP levels and Doppler echocardiographic parameters of left ventricle filling pressure in patients with Chagasic cardiomyopathy. Echocardiography 26: 521-527.
30. Walther T, Klostermann K, Heringer-Walther S, Schultheiss HP, Tschope C, et al. (2003) Fibrosis rather than blood pressure determines cardiac BNP expression in mice. Regul Pept 116: 95-100.
31. Factor SM, Tanowitz H, Wittner M, Ventura MC (1993) Interstitial connective tissue matrix alterations in acute murine Chagas' disease. Clin Immunol Immunopathol 68: 147-152.
32. Moreira Mda C, Heringer-Walther S, Wessel N, Moreira Ventura T, Wang Y, et al. (2008) Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation. Cardiology 110: 217-225.
33. Salomone OA, Caeiro TF, Madoery RJ, Amuchastegui M, Omelinauk M, et al. (2001) High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am J Cardiol 87: 1217-1220; A1217.
34. Perez-Fuentes R, Guegan JF, Barnabe C, Lopez-Colombo A, Salgado-Rosas H, et al. (2003) Severity of chronic Chagas disease is associated with cytokine/ antioxidant imbalance in chronically infected individuals. Int J Parasitol 33: 293-299.
35. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, et al. (2004) Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 38: 943-950.